Victory Portfolios IV has recently submitted its NPORT-P report, which provides an overview of its financial status as of August 31, 2026. This filing is significant as it offers insights into the company's asset management capabilities and performance metrics, particularly for its flagship fund, the Victory Pioneer Active Credit Fund.
The report indicates that Victory Portfolios IV, based in San Antonio, Texas, has total assets amounting to approximately $74.57 million, with total liabilities of around $12.60 million. This results in net assets of about $61.97 million. Such figures are essential for investors and stakeholders who are monitoring the fund's performance and overall health.
Background
Victory Portfolios IV is an investment management firm incorporated in Delaware. The company is classified under the investment sector, focusing on managing various funds and portfolios. Recent filings include several NPORT-P forms submitted on October 29, 2026, highlighting ongoing compliance with regulatory requirements. The firm operates primarily in the U.S. financial markets.
What the Filing Says
The latest NPORT-P filing, accession number 0001004726-26-010457, reveals critical financial data. The document states, "The total assets reported were $74,571,072.93, with total liabilities of $12,603,186.60, leading to net assets of $61,967,886.33." This information provides a snapshot of the fund's financial standing and its capacity to meet obligations.
Impact
The filing affects various stakeholders, including investors, analysts, and financial advisors who track the performance of investment funds. The reported figures may influence investment decisions and strategies, particularly concerning the Victory Pioneer Active Credit Fund, which is a key offering from Victory Portfolios IV.
What's Next
The filing does not specify what happens next, but it is likely that further updates will follow as the company continues to manage its portfolio and respond to market conditions.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






